<SEC-DOCUMENT>0001157523-18-000030.txt : 20180108
<SEC-HEADER>0001157523-18-000030.hdr.sgml : 20180108
<ACCEPTANCE-DATETIME>20180108073051
ACCESSION NUMBER:		0001157523-18-000030
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180108
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180108
DATE AS OF CHANGE:		20180108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		18514861

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51739104.htm
<DESCRIPTION>USANA HEALTH SCIENCES, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 10pt; font-family: Times New Roman">
    <p style="text-align: center">
      <br>
      <font style="font-size: 14pt; font-family: Times New Roman"><b>UNITED
      STATES</b></font><br><br><font style="font-size: 14pt; font-family: Times New Roman"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><br><br><font style="font-size: 12pt; font-family: Times New Roman"><b>WASHINGTON,
      D.C. 20549</b></font><br><font style="font-size: 12pt; font-family: Times New Roman">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 14pt; font-family: Times New Roman"><b>FORM 8-K</b></font><br><font style="font-size: 12pt; font-family: Times New Roman">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>CURRENT
      REPORT</b></font><br><br><font style="font-size: 10pt; font-family: Times New Roman">Pursuant
      to Section 13 or 15(d) of</font><br><br>t<font style="font-size: 10pt; font-family: Times New Roman">he
      Securities Exchange Act of 1934</font><br><br><font style="font-size: 10pt; font-family: Times New Roman">Date
      of Report (Date of Earliest Event Reported):</font><br><font style="font-size: 10pt; font-family: Times New Roman">January
      8, 2018</font><br><br><font style="font-size: 24pt"><b>USANA HEALTH
      SCIENCES, INC.</b></font><br><font style="font-size: 10pt; font-family: Times New Roman">(Exact
      name of registrant as specified in its charter)</font><br><br>Utah<br>(State
      or other jurisdiction of incorporation)<br><br>
    </p>
    <div style="text-align:center">
    <table cellspacing="0" style="font-size: 10pt; margin-left:auto;margin-right:auto; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td valign="bottom" style="text-align: center; width: 40%; padding-right: 0.0px; padding-left: 0.0px; white-space: nowrap">
          <p style="margin-bottom: 0px; margin-top: 0px">
            001-35024
          </p>
        </td>
        <td style="width: 20%">
          &#160;
        </td>
        <td valign="bottom" style="text-align: center; width: 40%; padding-right: 0.0px; padding-left: 0.0px; white-space: nowrap">
          <p style="margin-bottom: 0px; margin-top: 0px">
            87-0500306
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: center; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (Commission File No.)
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="top" style="text-align: center; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            (IRS Employer Identification
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="text-align: center; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="bottom" style="text-align: center; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Number)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <div style="text-align:center">
    <table cellspacing="0" style="font-size: 10pt; margin-left:auto;margin-right:auto; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            3838 West Parkway Boulevard<br>Salt Lake City, Utah 84120
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <font style="font-size: 10pt; font-family: Times New Roman">(Address
            of principal executive offices,</font> <font style="font-size: 10pt; font-family: Times New Roman">Zip
            Code)</font>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px">
          <p style="font-size: 10pt; font-family: Times New Roman">
            <font style="font-size: 10pt; font-family: Times New Roman">Registrant&#8217;s
            telephone number, including area code: </font><font style="font-size: 10pt">(801)
            954-7100</font>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      <br>

    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td valign="top" style="text-align: left; width: 5%; padding-left: 0.0px">
          <p style="font-size: 10pt">
            <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
          </p>
        </td>
        <td valign="top" style="text-align: left; width: 95%; padding-left: 0.0px">
          Indicate by check mark whether the registrant is an emerging growth
          company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
          &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17
          CFR &#167;240.12b-2).
        </td>
      </tr>
    </table>
    </div>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td valign="top" style="text-align: left; width: 5%; padding-left: 0.0px">
          <p style="font-size: 10pt">
            <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
          </p>
        </td>
        <td valign="top" style="text-align: left; width: 95%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            If an emerging growth company, indicate by check mark if the
            registrant has elected not to use the extended transition period
            for complying with any new or revised financial accounting
            standards provided pursuant to Section 13(a) of the Exchange Act.
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-right: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p>
      <b>Item 7.01 &#160;&#160;&#160;Regulation FD Disclosure</b>
    </p>
    <p>
      On January 8, 2018, USANA Health Sciences, Inc. (the &#8220;Company&#8221; or
      &#8220;USANA&#8221;) issued a press release announcing that it expects to take a
      one-time non-cash charge to its income statement following U.S. tax
      reform enacted on December 22, 2017.&#160;&#160;A copy of the press release is
      furnished herewith as Exhibit to this Current Report on Form 8-K and is
      incorporated herein by reference.&#160;&#160;This document will be posted on the
      Company&#8217;s corporate website, www.usana.com
    </p>
    <p>
      The information in this Current Report is being furnished and shall not
      be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities
      Exchange Act of 1934, as amended, or otherwise subject to the
      liabilities of that Section. The information in this Current Report
      shall not be incorporated by reference into any registration statement
      or other document pursuant to the Securities Act of 1933, as amended.
      The furnishing of the information in this Current Report is not intended
      to, and does not, constitute a representation that such furnishing is
      required by Regulation FD or that the information this Current Report
      contains is material investor information that is not otherwise publicly
      available.
    </p>
    <p>

    </p>
    <p style="white-space: nowrap">
      <b>Item&#160;9.01 &#160;&#160;&#160;Financial Statements and Exhibits. </b>
    </p>
    <p style="text-indent: 30.0px; white-space: nowrap">
      (d)&#160;&#160;Exhibits
    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td valign="top" style="text-align: left; width: 15%; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Exhibit No.</b>
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-bottom: 2.0px; width: 5%; padding-left: 0.0px">
          &#160;
        </td>
        <td valign="top" style="text-align: left; width: 80%; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Description</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: left; width: 15%; padding-right: 0.0px; padding-left: 0.0px; white-space: nowrap">
          <p style="margin-bottom: 0px; margin-top: 0px">
            99.1
          </p>
        </td>
        <td style="width: 5%">

        </td>
        <td valign="top" style="text-align: left; width: 80%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Press release issued by USANA Health Sciences, Inc. dated January
            8, 2018 (furnished herewith).
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: left">

    </p>
    <div style="margin-right: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <br>
      <font style="font-size: 10pt; font-family: Times New Roman"><b>SIGNATURES</b></font><br>
    </p>
    <p>
      Pursuant to the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.
    </p>
    <p style="text-align: justify; text-indent: 30.0px">

    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="text-align: left; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>USANA HEALTH SCIENCES, INC.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="text-align: left; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="text-align: left; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: left; width: 5%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="text-align: left; width: 55%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="text-align: left; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            By:<b> </b><u>/s/ G. Douglas
            Hekking&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="text-align: left; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            G. Douglas Hekking, Chief Financial Officer
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td valign="top" style="text-align: left; width: 40%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 55%">

        </td>
        <td style="width: 40%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: left; width: 5%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Date:
          </p>
        </td>
        <td valign="top" style="text-align: left; width: 55%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            January 8, 2018
          </p>
        </td>
        <td style="width: 40%">

        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-right: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <b>Exhibit Index</b>
    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; font-family: Times New Roman; margin-bottom: 10.0px">
      <tr>
        <td valign="top" style="text-align: left; width: 15%; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Exhibit No.</b>
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-bottom: 2.0px; width: 5%; padding-left: 0.0px">
          &#160;
        </td>
        <td valign="top" style="text-align: left; width: 80%; border-bottom-width: 1.0pt; padding-left: 0.0px; border-bottom-color: black; border-bottom-style: solid">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Description</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: left; width: 15%; padding-right: 0.0px; padding-left: 0.0px; white-space: nowrap">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <a href="a51739104ex99_1.htm">99.1</a>
          </p>
        </td>
        <td style="width: 5%">

        </td>
        <td valign="top" style="text-align: left; width: 80%; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <a href="a51739104ex99_1.htm">Press release issued by USANA Health
            Sciences, Inc. dated January 8, 2018 (furnished herewith).</a>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: left">

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a51739104ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-size: 8pt; font-family: Times New Roman">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>USANA
      Health Sciences Provides Estimated Impact of U.S. Tax Reform</b></font>
    </p>
    <p>
      SALT LAKE CITY--(BUSINESS WIRE)--January 8, 2018--USANA Health Sciences,
      Inc. (NYSE: USNA) today reported that it expects to take a one-time
      non-cash charge to its income statement following U.S. tax reform
      enacted on December 22, 2017. The preliminary estimate for this charge
      is expected to be approximately $33 million, which the Company will
      recognize in its fourth-quarter 2017 results in accordance with
      Generally Accepted Accounting Principles. The charge is largely due to
      foreign tax credits and other deferred tax assets that the Company does
      not expect to be able to realize under the new tax laws. An update of
      the estimated tax charge will be provided in the Company&#8217;s fourth
      quarter 2017 earnings release in February 2018.
    </p>
    <p>
      &#8220;Under the Company&#8217;s current global operating structure, we expect the
      Company&#8217;s effective tax rate to increase in 2018 under the recently
      enacted U.S. tax reform,&#8221; said Doug Hekking, Chief Financial Officer.
      &#8220;We are not prepared to provide an effective tax rate forecast for 2018
      at this time, because we are currently evaluating several operating and
      structural changes that may allow the Company to benefit from the new,
      lower U.S. tax rate prospectively. We will update investors regarding
      our expected 2018 income tax rate forecast when we provide our initial
      outlook in February.&#8221;
    </p>
    <p>
      <b>About USANA</b>
    </p>
    <p>
      USANA develops and manufactures high-quality nutritional supplements,
      healthy foods and personal care products that are sold directly to
      Associates and Preferred Customers throughout the United States, Canada,
      Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea,
      Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the
      United Kingdom, Thailand, France, Belgium, Colombia and Indonesia. More
      information on USANA can be found at <u>www.usana.com</u>.
    </p>
    <p>
      CONTACT:<br>USANA Health Sciences, Inc.<br>Investors contact:<br>Patrique
      Richards, 801-954-7961<br>Investor Relations<br><u>investor.relations@us.usana.com</u><br>or<br>Media
      contact:<br>Dan Macuga, 801-954-7280<br>Public Relations
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
